Literature DB >> 21676449

Oxalate and sucralose absorption in idiopathic calcium oxalate stone formers.

John Knight1, Juquan Jiang, Kyle D Wood, Ross P Holmes, Dean G Assimos.   

Abstract

OBJECTIVES: To better understand intestinal oxalate transport by correlating oxalate and sucralose absorption in idiopathic calcium oxalate stone formers. Oxalate has been hypothesized to undergo absorption in the large and small intestine by both paracellular and transepithelial transport. Sucralose is a chlorinated sugar that is absorbed by paracellular mechanisms.
METHODS: Idiopathic calcium oxalate stone formers were recruited to provide urine specimens on both a self-selected diet and after a meal containing 90 mg of (13)C(2-)oxalate and 5 g of sucralose, and a stool sample for determination of Oxalobacter formigenes colonization. The 24-hour urine collections were fractionated into the first 6 hours and the subsequent 18 hours. Sucralose and oxalate excretion were measured during these periods and used to estimate absorption.
RESULTS: Thirty-eight subjects were evaluated. The majority of both the (13)C(2-)oxalate and sucralose absorption occurred within the 0-6-hour collection. The (13)C(2-)oxalate and sucralose absorptions were significantly correlated at the 0-6 hour, the 6-24 hour, and the total 24-hour time periods (P <.04). All 5 oxalate hyperabsorbers(>15% absorption) also absorbed significantly more sucralose during the 0-6 hour and whole 24-hour time points (P <.04). Oxalobacter formigenes colonization did not significantly alter oxalate absorption.
CONCLUSIONS: The results suggest that most oxalate is absorbed in the proximal portion of the gastrointestinal tract and that paracellular transport is involved. Augmented paracellular transport, as evidenced by increased sucralose absorption, may also influence oxalate absorption.
Copyright © 2011 Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21676449      PMCID: PMC3152675          DOI: 10.1016/j.urology.2011.04.008

Source DB:  PubMed          Journal:  Urology        ISSN: 0090-4295            Impact factor:   2.649


  22 in total

1.  Contribution of dietary oxalate to urinary oxalate excretion.

Authors:  R P Holmes; H O Goodman; D G Assimos
Journal:  Kidney Int       Date:  2001-01       Impact factor: 10.612

2.  Diet, but not oral probiotics, effectively reduces urinary oxalate excretion and calcium oxalate supersaturation.

Authors:  John C Lieske; William J Tremaine; Claudio De Simone; Helen M O'Connor; Xujian Li; Eric J Bergstralh; David S Goldfarb
Journal:  Kidney Int       Date:  2010-08-25       Impact factor: 10.612

Review 3.  Intestinal transport of an obdurate anion: oxalate.

Authors:  Marguerite Hatch; Robert W Freel
Journal:  Urol Res       Date:  2004-11-25

4.  Dietary oxalate loads and renal oxalate handling.

Authors:  Ross P Holmes; Walter T Ambrosius; Dean G Assimos
Journal:  J Urol       Date:  2005-09       Impact factor: 7.450

Review 5.  Intestinal permeability: an overview.

Authors:  I Bjarnason; A MacPherson; D Hollander
Journal:  Gastroenterology       Date:  1995-05       Impact factor: 22.682

6.  Variability of gastrointestinal transit in healthy women and men.

Authors:  L P Degen; S F Phillips
Journal:  Gut       Date:  1996-08       Impact factor: 23.059

7.  Discrimination of site-specific alterations in gastrointestinal permeability in the rat.

Authors:  J B Meddings; I Gibbons
Journal:  Gastroenterology       Date:  1998-01       Impact factor: 22.682

8.  Assessment of oxalate absorption from almonds and black beans with and without the use of an extrinsic label.

Authors:  Weiwen Chai; Michael Liebman
Journal:  J Urol       Date:  2004-09       Impact factor: 7.450

9.  Evaluation of a triple sugar test of colonic permeability in humans.

Authors:  A D G Anderson; P K Jain; S Fleming; P Poon; C J Mitchell; J MacFie
Journal:  Acta Physiol Scand       Date:  2004-10

10.  Oxalobacter sp. reduces urinary oxalate excretion by promoting enteric oxalate secretion.

Authors:  M Hatch; J Cornelius; M Allison; H Sidhu; A Peck; R W Freel
Journal:  Kidney Int       Date:  2006-02       Impact factor: 10.612

View more
  4 in total

1.  Inhibition of urinary stone disease by a multi-species bacterial network ensures healthy oxalate homeostasis.

Authors:  Aaron W Miller; David Choy; Kristina L Penniston; Dirk Lange
Journal:  Kidney Int       Date:  2019-02-28       Impact factor: 10.612

2.  Intestinal permeability in subjects from two different race groups with diverse stone-risk profiles.

Authors:  Takalani Theka; Allen Rodgers; Neil Ravenscroft; Sonja Lewandowski
Journal:  Urolithiasis       Date:  2013-01-22       Impact factor: 3.436

3.  Presence of Oxalobacter formigenes in the intestinal tract is associated with the absence of calcium oxalate urolith formation in dogs.

Authors:  Josephine S Gnanandarajah; Juan E Abrahante; Jody P Lulich; Michael P Murtaugh
Journal:  Urol Res       Date:  2012-01-06

4.  Distinguishing characteristics of idiopathic calcium oxalate kidney stone formers with low amounts of Randall's plaque.

Authors:  Xiangling Wang; Amy E Krambeck; James C Williams; Xiaojing Tang; Andrew D Rule; Fang Zhao; Eric Bergstralh; Zejfa Haskic; Samuel Edeh; David R Holmes; Loren P Herrera Hernandez; John C Lieske
Journal:  Clin J Am Soc Nephrol       Date:  2014-08-04       Impact factor: 8.237

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.